Who
Edward Moore Kennedy Jr.
Director
Company insider
Files Form 4 as: Director, InnovAge Holding; Director, Arvinas.
In numbers
- Trades disclosed
- 23
- Buys
- 3
- Sells
- 0
- Bought
- $1.0M
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 26 Sep 2018
- Last trade
- 1 Jul 2026
- Last filed
- 2 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jul 2026filed 2 Jul 2026 | INNV InnovAge HoldingProviders & Facilities | SEC FORM 4 Code A | —8,539 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | INNV InnovAge HoldingProviders & Facilities | SEC FORM 4 Code A | —8,539 at $0.00 | filing |
| 24 Jun 2026filed 26 Jun 2026 | ARVN ArvinasBiotechnology | SEC FORM 4 Code A | —15,527 at $0.00 | filing |
| 24 Jun 2026filed 26 Jun 2026 | ARVN Arvinasoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,714 at $0.00 | filing |
| 24 Jun 2026filed 26 Jun 2026 | ARVN Arvinasoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,714 at $0.00 | filing |
| 24 Jun 2026filed 26 Jun 2026 | ARVN ArvinasBiotechnology | SEC FORM 4 Code A | —15,527 at $0.00 | filing |
| 1 Jul 2025filed 2 Jul 2025 | INNV InnovAge HoldingProviders & Facilities | SEC FORM 4 Code A | —25,316 at $0.00 | filing |
| 25 Jun 2025filed 27 Jun 2025 | ARVN Arvinasoption or derivative · Biotechnology | SEC FORM 4 Code A | —23,105 at $0.00 | filing |
| 25 Jun 2025filed 27 Jun 2025 | ARVN ArvinasBiotechnology | SEC FORM 4 Code A | —16,025 at $0.00 | filing |
| 5 Sep 2024filed 5 Sep 2024 | INNV InnovAge HoldingProviders & Facilities | SEC FORM 4 Code A | —19,841 at $0.00 | filing |
| 29 May 2024filed 31 May 2024 | ARVN Arvinasoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,070 at $0.00 | filing |
| 29 May 2024filed 31 May 2024 | ARVN ArvinasBiotechnology | SEC FORM 4 Code A | —5,899 at $0.00 | filing |
| 15 Jun 2023filed 20 Jun 2023 | ARVN Arvinasoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,787 at $0.00 | filing |
| 15 Jun 2023filed 20 Jun 2023 | ARVN ArvinasBiotechnology | SEC FORM 4 Code A | —4,121 at $0.00 | filing |
| 16 Jun 2022filed 21 Jun 2022 | ARVN Arvinasoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,192 at $0.00 | filing |
| 8 Jun 2021filed 10 Jun 2021 | ARVN Arvinasoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,511 at $0.00 | filing |
| 6 Apr 2021filed 28 Jan 2022 | ARVN ArvinasBiotechnology | SEC FORM 4 Code G | —29,333 at $0.00 | filing |
| 8 Mar 2021filed 8 Mar 2021 | INNV InnovAge HoldingProviders & Facilities | SEC FORM 4 Bought | $483K23,000 at $21.00 | filing |
| 9 Nov 2020filed 12 Nov 2020 | ARVN ArvinasBiotechnology | SEC FORM 4 Bought | $200K8,333 at $23.99 | filing |
| 3 Jun 2020filed 4 Jun 2020 | ARVN Arvinasoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.